Thrombocytopenia in the antiphospholipid syndrome

Br J Haematol. 1996 Apr;93(1):1-5. doi: 10.1046/j.1365-2141.1996.390969.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Antiphospholipid / metabolism
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / diagnosis*
  • Antiphospholipid Syndrome / metabolism
  • Blood Platelets / metabolism
  • Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Humans
  • Interleukin-3 / adverse effects
  • Interleukin-3 / therapeutic use
  • Recombinant Fusion Proteins / adverse effects
  • Recombinant Fusion Proteins / therapeutic use
  • Thrombocytopenia / drug therapy
  • Thrombocytopenia / etiology*
  • Thrombocytopenia / metabolism
  • Thrombosis / complications
  • Thrombosis / metabolism

Substances

  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Interleukin-3
  • PIXY321 fusion protein, recombinant
  • Recombinant Fusion Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor